BlackRock Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$129K Buy
7,295
+697
+11% +$15K ﹤0.01% 2916
2016
Q3
$154K Buy
6,598
+491
+8% +$11.1K ﹤0.01% 2818
2016
Q2
$114K Buy
6,107
+641
+12% +$11.6K ﹤0.01% 2906
2016
Q1
$99K Buy
5,466
+413
+8% +$6.65K ﹤0.01% 2923
2015
Q4
$106K Sell
5,053
-2,633
-34% -$50.7K ﹤0.01% 2897
2015
Q3
$142K Sell
7,686
-1,006
-12% -$25.1K ﹤0.01% 2927
2015
Q2
$294K Sell
8,692
-936
-10% -$37.7K ﹤0.01% 2562
2015
Q1
$463K Buy
9,628
+2,079
+28% +$94.3K ﹤0.01% 2129
2014
Q4
$168K Sell
7,549
-434
-5% -$10K ﹤0.01% 2741
2014
Q3
$151K Sell
7,983
-45,325
-85% -$1.08M ﹤0.01% 2771
2014
Q2
$1.44M Buy
53,308
+12,706
+31% +$322K ﹤0.01% 1292
2014
Q1
$1.31M Sell
40,602
-29,662
-42% -$964K ﹤0.01% 1364
2013
Q4
$1.67M Buy
+70,264
New +$1.96M ﹤0.01% 1247

Other funds holding FMI

BlackRock Advisors's FMI Position: Q4 2016 in Review

BlackRock Advisors increased its Foundation Medicine, Inc. (FMI) stake by 11% in Q4 2016, buying an estimated $15K and bringing the position to 7,295 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #2916.

BlackRock Advisors first reported a position in FMI in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.67M in Q4 2013. 95 funds tracked by Wall St. Rank hold FMI as of Q4 2016.

  • BlackRock Advisors held 7,295 shares of Foundation Medicine, Inc. worth $129K as of Q4 2016.
  • BlackRock Advisors bought 697 Foundation Medicine, Inc. shares in Q4 2016, an estimated $15K.
  • Foundation Medicine, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2916 holding.
  • BlackRock Advisors first reported a position in Foundation Medicine, Inc. in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Advisors's Foundation Medicine, Inc. position peaked at $1.67M in Q4 2013.
  • 95 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.